Literature DB >> 29449307

RAGE Deletion Confers Renoprotection by Reducing Responsiveness to Transforming Growth Factor-β and Increasing Resistance to Apoptosis.

Shinji Hagiwara1,2, Karly Sourris1,2, Mark Ziemann1,2, Wu Tieqiao1,2, Muthukumar Mohan1,2, Aaron D McClelland2, Eoin Brennan1,2, Josephine Forbes3, Melinda Coughlan1,2, Brooke Harcourt4, Sally Penfold1,2, Bo Wang2,5, Gavin Higgins1,2, Raelene Pickering1,2, Assam El-Osta1,2, Merlin C Thomas1,2, Mark E Cooper1,2, Phillip Kantharidis6,2.   

Abstract

Signaling via the receptor of advanced glycation end products (RAGE)-though complex and not fully elucidated in the setting of diabetes-is considered a key injurious pathway in the development of diabetic nephropathy (DN). We report here that RAGE deletion resulted in increased expression of fibrotic markers (collagen I and IV, fibronectin) and the inflammatory marker MCP-1 in primary mouse mesangial cells (MCs) and in kidney cortex. RNA sequencing analysis in MCs from RAGE-/- and wild-type mice confirmed these observations. Nevertheless, despite these gene expression changes, decreased responsiveness to transforming growth factor-β was identified in RAGE-/- mice. Furthermore, RAGE deletion conferred a more proliferative phenotype in MCs and reduced susceptibility to staurosporine-induced apoptosis. RAGE restoration experiments in RAGE-/- MCs largely reversed these gene expression changes, resulting in reduced expression of fibrotic and inflammatory markers. This study highlights that protection against DN in RAGE knockout mice is likely to be due in part to the decreased responsiveness to growth factor stimulation and an antiapoptotic phenotype in MCs. Furthermore, it extends our understanding of the role of RAGE in the progression of DN, as RAGE seems to play a key role in modulating the sensitivity of the kidney to injurious stimuli such as prosclerotic cytokines.
© 2018 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29449307     DOI: 10.2337/db17-0538

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  6 in total

1.  Receptor of Advanced Glycation End Products Deficiency Attenuates Cisplatin-Induced Acute Nephrotoxicity by Inhibiting Apoptosis, Inflammation and Restoring Fatty Acid Oxidation.

Authors:  Qiang Wang; Yuemei Xi; Binyang Chen; Hairong Zhao; Wei Yu; Weidong Liu; Furong He; Chenxi Xu; Jidong Cheng
Journal:  Front Pharmacol       Date:  2022-05-30       Impact factor: 5.988

2.  A Network Pharmacology Approach to Explore the Mechanism of HuangZhi YiShen Capsule for Treatment of Diabetic Kidney Disease.

Authors:  Xue-Feng Zhou; Wei-E Zhou; Wen-Jing Liu; Min-Jing Luo; Xia-Qing Wu; Ying Wang; Peng Liu; Yu-Min Wen; Jia-Lin Li; Ting-Ting Zhao; Hao-Jun Zhang; Hai-Ling Zhao; Ping Li
Journal:  J Transl Int Med       Date:  2021-06-18

3.  Proximal tubular RAGE mediated the renal fibrosis in UUO model mice via upregulation of autophagy.

Authors:  Bohao Liu; Tianshi Sun; Huiling Li; Shuangfa Qiu; Yijian Li; Dongshan Zhang
Journal:  Cell Death Dis       Date:  2022-04-23       Impact factor: 9.685

4.  Deletion of RAGE fails to prevent hepatosteatosis in obese mice due to impairment of other AGEs receptors and detoxifying systems.

Authors:  Casper G Schalkwijk; Raffaella Mastrocola; Kristiaan Wouters; Alessia S Cento; Katrien H Gaens; Margee Teunissen; Jean L J M Scheijen; Federica Barutta; Fausto Chiazza; Debora Collotta; Manuela Aragno; Gabriella Gruden; Massimo Collino
Journal:  Sci Rep       Date:  2021-08-30       Impact factor: 4.379

Review 5.  The Role of AGE-RAGE Signalling as a Modulator of Gut Permeability in Diabetes.

Authors:  Matthew Snelson; Elisa Lucut; Melinda T Coughlan
Journal:  Int J Mol Sci       Date:  2022-02-03       Impact factor: 5.923

Review 6.  Pathophysiology of RAGE in inflammatory diseases.

Authors:  Hanbing Dong; Yue Zhang; Yu Huang; Hui Deng
Journal:  Front Immunol       Date:  2022-07-29       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.